Argireline (Acetyl Hexapeptide-3)
Argireline is a synthetic hexapeptide that mimics the N-terminal portion of SNAP-25, competitively inhibiting the SNARE complex to reduce muscle micro-contraction and expression line depth.
Protocol
5–10% in topical formulations
Half-Life
N/A (topical)
Molecular Structure & Chemistry
20 residues • 322 atoms • Skeletal Formula
C105H156N24O33S4
2,050.5 g/mol
2409.016 Da
4.39
-1.19
-0.88
Amino Acid Sequence
Biological Mechanisms
Wrinkle reduction
Observed in clinical research as a primary mechanism of action for Argireline (Acetyl Hexapeptide-3).
Topical Botox-like effect
Observed in clinical research as a primary mechanism of action for Argireline (Acetyl Hexapeptide-3).
Reduced muscle micro-contraction
Observed in clinical research as a primary mechanism of action for Argireline (Acetyl Hexapeptide-3).
Skin smoothing
Observed in clinical research as a primary mechanism of action for Argireline (Acetyl Hexapeptide-3).
Non-injectable anti-aging
Observed in clinical research as a primary mechanism of action for Argireline (Acetyl Hexapeptide-3).
Safety & Risk Analysis
Critical Safety Warning
Black market peptides can be contaminated, mislabeled, or dangerous. Only obtain peptides via a registered doctor and legitimate pharmacy. Never attempt self-administration without professional medical supervision.
Community Journey Log
Log Your Journey
Share your research observations with the community.
Sign in to contribute
Create a free account to log your research journey and share observations with the community.
Community Observations (0)
No journey logs yet. Be the first to share.
This compound is for research purposes only. Clinical applications must be directed by a licensed physician.
View Community Logs